Loading...
Loading...
Intermolecular, Inc.
IMI accelerating research and development (R&D) for semiconductor and
clean-energy industries—today announced that its intellectual property (
IP)
portfolio has increased to 730 U.S. patents and patent applications. The
company now owns or has exclusive rights to this portfolio which covers both
its HPC innovation platform and the inventions resulting from deploying the
platform for the benefit of its customers. The company filed 207 US patent
applications in 2011, spanning innovations in semiconductor technology
including advanced logic, DRAM, and Non-volatile Memory (NVM), as well as in
clean-energy fields such as photovoltaics (PV), light-emitting diodes (
LED),
and energy-efficient glass.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in